Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00682890 · ClinicalTrials.gov registry record · Phase 4
Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)
A Phase 4 study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT00682890 is a Phase 4 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 28 participants.
The verdict
NCT00682890, a Phase 4 study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if adding Metformin, a drug that reduces insulin resistance, to birth control pills will reduce the risk of developing type 2 diabetes, high blood pressure. high lipid levels and heart disease in women with PCOS
Interventions
- DRUG placebo
- DRUG metformin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2005-11 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00682890
The ClinicalTrials.gov registry entry for NCT00682890 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00682890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00682890 about?
NCT00682890 is a clinical study titled "Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)". The purpose of this research study is to determine if adding Metformin, a drug that reduces insulin resistance, to birth control pills will reduce the risk of developing type 2 diabetes, high blood pressure. high lipid levels and heart disease in women with PCOS
What is the current status of trial NCT00682890?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2005-11. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00682890?
The interventions under investigation include: placebo (DRUG), metformin (DRUG).
Who is sponsoring clinical trial NCT00682890?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.